You are about to leave the Clinical Value website now.

Cancel

Moving towards risk-based surveillance and early detection of hepatocellular carcinoma

LCS23_Gio-template-Mailchimp-1200x400-4

Quick Summary

Dr. Amit Singal and Dr. Peter Jepson review the latest developments in risk-based surveillance and the early detection of hepatocellular carcinoma during the EASL Liver Cancer Summit 2023, in light of the recent EASL policy statement for patients with cirrhosis.

You May Also Like

27 June 2024

Cost-Utility of Novel Biomarker-Based Strategies for Hepatocellular Carcinoma (HCC) Surveillance in Thailand

Read More

SHARE

Be the first to receive updates, event opportunities, and thought leadership insights.